A Product People Liked Still Felt “Not for Me”

I was the founders’ only researcher, running six weeks of usability and non-completer research to learn why sign-ups had stalled. The channel strategy that came out of it took the platform from fewer than 20 users to more than 16,000.

TL;DR

What was at stake
The company needed to grow past friends and early adopters to a real user base before its runway ran out.
What changed
The founders added employer and union channels alongside direct-to-consumer, and started re-engagement emails for trial users who never converted. Outreach to advocacy groups such as NAACP was underway when the engagement ended.
My role
Solo researcher and strategist for the founders, from study design and recruiting through sessions, behavioral analytics, and recommendations
Timeline
About 3.5 months: 6 weeks of research through the January readout, then advisory through March
Measurable outcome
16,000+

Users, up from fewer than 20, mostly friends and people paid to sign up. Past the founders’ 10,000-user target.

1st

Six-figure service agreement, which came directly from the employer and union channel.

Shipped

Employer and union channels alongside direct-to-consumer, and re-engagement emails for trial users who never subscribed.

Recommendation
Introduce the product through institutions people already trust
Some people saw its value but felt it was meant for someone else. Others didn’t trust it enough to try it, and no compliance badge could change that.
Evidence
11 of 19
people backed out before trying the product, most of them over privacy and trust.
Before
Direct to consumer
Each person decides alone
“Do I need this? Should I trust it? Is this for me?”
After
Employer or union benefit
The institution vouches for it
“My organization already chose this for me.”
Target 10,000 users through employer and union partnerships
AI Health Platform (NDA)Adapted for this portfolio
Aha moment

Partway through building personas, I realized sharper targeting wouldn’t help. People either didn’t trust the product or didn’t think it was for them.

Read the full case study

Meet people through someone they already trust

The Trust-Transfer Model introduces the product through an institution people already trust, like their employer or union.

Strategic Framework
The Trust-Transfer Model
Original approachDirect to consumer
Research recommendationTrust transfer (B2B2C)
How people meet it
Direct to consumerThey find the product on their own.
Trust transferA self-funded employer, union, stop-loss carrier, or advocacy organization (AARP, Alzheimer’s Association, NAACP health initiatives) offers it as a benefit.
What carries trust
Direct to consumerCompliance badges and HIPAA and SOC 2 disclosures, which didn’t move the people who backed out.
Trust transferThe institution’s credibility, borrowed before the product has earned its own.
The “Not for Me” Paradox
Direct to consumerEvery signup has to get past optimism bias on its own.
Trust transferThe organization frames it as relevant, so the product can prove itself at population scale.
What it costs
Direct to consumerA valid path, with substantial acquisition cost.
Trust transferLower acquisition cost and less psychological friction.
Primary
Recommendation
Offer it through employers and unions

Partner with self-funded employers, stop-loss carriers, unions, and other trusted groups to offer the product as a benefit. Start where the value is easy for the employer to see: burnout among healthcare workers, time lost by professionals caring for aging parents, and absenteeism in manufacturing.

Complementary
Channel
Borrow trust from advocacy groups

Seek endorsements from groups like the Alzheimer’s Association, caregiver alliances, AARP, and NAACP health initiatives, so people who find the product on their own see a name they recognize.

Validation
Before Scale
Run a 30-day pilot first

Test the partner approach with a 30-day pilot before shifting the whole go-to-market plan, with a clear point to stop if it didn’t reduce the friction I saw in research.

Retention
Quick Win
Follow up with trial users

Behavioral analytics showed no follow-up with people who started a free trial and didn’t subscribe. I recommended a short re-engagement email sequence for them, since the cost of reaching them had already been spent.

The tension

The partner channel was the bigger bet, so I also recommended a 30-day pilot with a clear point to stop before the founders moved their whole go-to-market.

The founders saw a product problem

The founders’ hypothesis

Adoption is a product or feature problem.

What the research showedNot supported

The interface had a few rough spots, but nothing that explained the drop-off. People were leaving at the entry point.

My hypothesis

People who backed out of participating had something to add, even without trying the product.

What would have changed my mindIf the people who backed out had given usability reasons, like setup taking too long, I’d have kept the focus on the product.

What the research showedSupported

The reasons people gave for backing out became the trust finding.

A product that worked and a growth problem

The client was an early-stage AI health platform built to work like a personal medical command center: one place for your health history, appointment prep, and a check on possible diagnostic errors. The technology worked and had early clinical backing. Getting people to sign up and stay was the problem.

I was brought in to run usability research and find out where people were dropping off. I worked directly with the founders, with no PM or design team in between, and presented findings that challenged the go-to-market plan they had built.

Following the people who said no

I recruited and screened everyone myself, across a range of ages, health engagement, and comfort with technology, and ran the sessions over Zoom.

1
Screener survey
Recruited and qualified participants independently across varied health engagement profiles
2
Think-aloud usability
8 moderated sessions observing real-time navigation and verbal reasoning through the product
3
Semi-structured interviews
Post-session interviews exploring attitudes toward health data, AI, and personal health management
4
Non-completer analysis
Conversations with people who refused to try the product
5
Behavioral analytics
Analyzed site and in-product behavior to find drop-off points and check them against what people said
Approach and time allocation · about 6 weeks
Discussion guide and screener · 4 days
Recruiting · 2 weeks, over the holidays
The screener stayed open through the break, so sessions could start the first week of January.
Sessions, refusals, and behavioral data · 2 weeks
Moved the question from usability to who people thought the product was for.
Synthesis · 1 week
Turned the findings into a channel recommendation.
Readout · 4 days

Eight sessions were enough to find the pattern. The 11 people who backed out added evidence for the trust finding.

A pipeline that saved 6 to 7 working days

I set up the analysis as a chain, with AI doing the first pass at each stage and me checking its work before the next one started. A short script I wrote handled the file conversion, so transcripts went from recording to coding in a day.

Analysis pipeline
6 to 7 working days saved in a six-week study
  1. AI
    Transcribe
    Sessions transcribed automatically.
  2. Script I wrote
    Convert
    I wrote a script to convert transcripts to .vtt, so they loaded into Dovetail the same day.
    3–4 days saved
  3. Me
    Verify
    Every transcript checked against its recording, since the automated ones had errors.
  4. AI
    Cluster
    Dovetail’s AI grouped themes across sessions as a first pass.
    ~2 days saved
  5. Me
    Code
    I did the coding from there, starting from the AI’s groups.
  6. AI
    Draft
    Notion AI drafted slide copy from my theme notes.
    ~1 day saved
  7. Me
    Triangulate
    Saved time went into checking what people said against the behavioral data.
AI first passScript I wroteMy check

People liked it. Most decided it wasn’t for them.

Behavioral analytics and interviews indicated the same thing. The bigger findings were about whether people saw the product as something for them.

Who the research heard from
More people backed out than tried it
8
Moderated think-aloud sessions

All 8 accepted the concept. 7 still saw the product as meant for someone else.

11
Backed out after the introduction

Refused over privacy and trust.

I kept the people who backed out in the analysis instead of dropping them as non-completers.
1
The “Not for Me” Paradox

Most named someone else it would help: a parent, a grandparent, a friend with a chronic illness. Some said they would use it if their doctor told them to. That’s optimism bias, the belief that health risks apply more to other people, and I named it the “Not for Me” Paradox so the founders had a handle for it.

2
Compliance badges didn’t build trust

The people who backed out had already heard the product was HIPAA and SOC 2 compliant. For them, feeling safe was something the product hadn’t earned yet, and a badge on the page couldn’t supply it.

3
Confidence labels didn’t make unexpected diagnoses any easier to believe

The platform never said whether a doctor was right or wrong. It listed possible diagnoses, each labeled with a level of likelihood, and the doctor’s diagnosis might or might not be on the list. More than half of the participants were skeptical of anything out of the ordinary, and a high-confidence label on an unusual diagnosis made them question it more. They wanted someone they already trusted to back it up, which became another piece of the logic behind the trust-transfer recommendation.

“I totally get why someone with a chronic illness or like an elderly parent would need this. It would actually be really great for my nana, but personally, I’m super healthy so I don’t need it.”

Research participant, on the “Not for Me” Paradox

“If my primary told me, ‘Hey, download this app before our next visit,’ I would probably do it. But just finding it on my own? I’d assume it’s for people with way more complex medical histories.”

Research participant, on who the product is for

“I saw the page says it’s HIPAA compliant, but nowadays everyone says they’re secure until a data breach happens. I’m just uncomfortable uploading my full medical records to a startup I’ve never heard of.”

Research participant, on trust
What it meant for growth
Selling direct to consumers would mean paying to overcome distrust and optimism bias one person at a time.

Impact

This was the first time I delivered something other than what a client asked for, knowing it might not be welcome. For the founders, it replaced guesswork about who to target with a clear reason people weren’t signing up.

Hindsight

1
Test onboarding on its own

The research pointed to the entry point as the problem, but the sessions covered the whole product. A study built only around first-time activation would have shown exactly where trust broke down.The founders would have had a specific screen to fix alongside the channel change.

2
Push for one interface change to measure

The founders’ changes were about channels, not the interface, so there was nothing new to bring back into testing. I would push for one onboarding change alongside the strategy work, so a follow-up study could measure the result.The founders would have had a before-and-after number to bring to partners, not just user growth.

3
Recruit caregivers from the start

Caregivers came up during analysis as a strong segment, but I hadn’t recruited them on purpose. Building them into the screener from day one would have given that group its own findings and likely sped up the partner recommendation.The advocacy outreach could have started weeks sooner, with findings behind it.

With two more weeks

1
Study caregivers on their own

Recruit caregivers directly and give them their own sessions.

2
Test the pitch with benefits buyers

Employers decide through HR and benefits teams, so the partner pitch needs testing with them too.